Use of osmic acid in the topical treatment of exudative synovitis of the knee joint.
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002358:Cartilage, Articular / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005500:Follow-Up Studies; D006801:Humans; D007270:Injections, Intra-Articular; D007719:Knee Joint; D008875:Middle Aged; D009992:Osmium / Q000627:therapeutic use*; D009993:Osmium Tetroxide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D000074402:Synovectomy; D013585:Synovitis / Q000188:drug therapy*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D010919:Placebos; D015021:Yttrium Radioisotopes; D009992:Osmium; D009993:Osmium Tetroxide